The SPAC has said it is targeting the life sciences sector. Total capitalization stands at $101.5M, according to the filing. Read more.
Related Posts
ION Acquisition 2 Shares & Warrants to Begin Separate Trading
The SPAC raised $220 million in a January IPO to target tech companies in Israel.
Legacy Schedules to Vote on Merger Deadline Extension
One reason for the delay, the SPAC said in the filing, is due to ongoing litigation brought by minority shareholders in Onyx Enterprises, the merger target.
World Quantum Growth Cuts Deal Size by 33% Ahead of $200M IPO
The new SPAC is targeting the FinTech sector in the U.S. and EMEA.
Alpha Capital’s SPAC Closes $230M IPO
The SPAC will use the funds to seek a business combination with a Latin American-focused technology company.